| abstract |
FIELD: medicine. n SUBSTANCE: invention relates to medicine and describes the application of 2'-fucosyllactose for manufacturing an enteral composition, and the said composition is not human milk, for treatment and/or prevention of viral infections, caused by orthomyxoviridae, in particular influenza virus, herpes virus, rotavirus, cytomegalovirus, respiratory-syncytial virus, human immunodeficiency virus and/or rhinovirus, and also describes the application of 2'-fucosyllactose for manufacturing the enteral composition for enhancement of a response to vaccination, preferably for enhancement of the response to vaccination in case of vaccination with a viral antigen. n EFFECT: application of 2'-fucosyllactose makes it possible to increase the natural protection against viral infections and tumour cells. n 15 cl, 5 ex, 2 tbl |